Table 3 Characterization of NK cell ligands on gastric tumor cells
| Â | Patient 1 (N = 2) | Patient 2 (N = 3) | ||
|---|---|---|---|---|
| Â | Mean | Range | Mean | Range |
Inhibitory ligands | ||||
HLA class 1 | 75% | 71%-80% | 67% | 30%-97% |
HLA-E | 1% | 0%-1% | 2% | 1%-3% |
HLA-G | 42% | 28%-56% | 57% | 30%-82% |
Activating ligands | ||||
PVR | 8% | 3%-14% | 9% | 3%-18% |
Nectin-2 | 92% | 87%-98% | 92% | 87%-97% |
MIC A/B | 2% | 1%-2% | 1% | 0%-1% |
ULBP-1 | 3% | 2%-4% | 3% | 2%-4% |
ULBP-2 | 62% | 60%-65% | 67% | 51%-76% |
ULBP-3 | 3% | 3%-4% | 3% | 2%-4% |
Other | Â | Â | Â | Â |
Fas | 36% | 21%-50% | 95% | 88%-99% |
EGFR | 95% | 93%-98% | 18% | 7%-29% |